1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Joy Hu
Joy Hu
Articles (181) 

Weekly CEO Buys Highlight

Details the CEO buys this past week from the following companies: OPKO Health, Intercept Pharmaceuticals, New Media Investment Group, Macy's and Aclaris Therapeutics

April 16, 2018 | About:

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

OPKO Health CEO bought 294,527 shares

OPKO Health Inc. (NASDAQ:OPK) CEO, Chairman and 10% Owner Phillip Frost bought 294,527 shares during the week at an average price of $3.06.

The diversified health care company, whose business includes diagnostics and provision of pharmaceutical products, has a market cap of $1.67 billion. Its shares traded around $2.99 on Friday.

Consolidated revenue for the quarter ended Dec. 31 was $193.7 million, compared to $275.5 million in the prior-year period.

Frost bought 60,000 shares on April 6 at a price of $3.10; 80,000 shares on April 9 at a price of $3.04; 36,527 shares on April 10 at a price of $3.06; 43,000 shares on April 11 at a price of $3.06; and 65,000 shares on April 12 at a price of $3.04. The price of the stock has decreased by 1.64% since.

Director Robert Scott Fishel bought 10,000 shares on April 6 at a price of $3.16. The price of the stock has decreased by 5.38% since.

Intercept Pharmaceuticals CEO bought 7,812 shares

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) CEO and President Mark Pruzanski bought 7,812 shares on April 9 at a price of $64.00. The price of the stock has increased by 14.17% since.

Intercept Pharmaceuticals is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need. The company has a market cap of $1.84 billion. Its shares traded at $73.07 on Friday.

Net loss for the three months ended Dec. 31, 2017, was $111.3 million compared to a net loss of $120.0 million for the prior-year period.

On April 5 the company announced that it priced its public offering of 2,343,750 shares of its common stock at a price to the public of $64.00 per share.

10% Owner Genextra S.p.A bought 390,625 shares on April 9 at a price of $64. The price of the stock has increased by 14.17% since.

10% Owner Francesco Micheli bought 390,625 shares on April 9 at a price of $64. The price of the stock has increased by 14.17% since.

Director Keith Michael Gottesdiener bought 1,171 shares on April 9 at a price of $64. The price of the stock has increased by 14.17% since.

Director Daniel Bradbury bought 7,812 shares on April 9 at a price of $64. The price of the stock has increased by 14.17% since.

New Media Investment Group CEO bought 25,000 shares

New Media Investment Group Inc. (NYSE:NEWM) CEO Michael Reed bought 25,000 shares on April 10 at a price of $16.45. The price of the stock has increased by 3.95% since.

New Media Investment Group owns, operates and invests in local media assets. The company focuses on two categories, consumers and small to medium-sized businesses. The company has a market cap of $904.33 million. Its shares traded at $17.10 on Friday.

Net income for the fourth quarter was $26.4 million compared to net loss of $2.0 million for the prior-year period.

On April 5 the company announced the launch of its public offering of 6 million shares of its common stock.

Macy's CEO bought 10,000 shares

Macy's Inc. (NYSE:M) Chairman and CEO Jeffrey Gennette bought 10,000 shares on April 12 at a price of $29.10. The price of the stock has decreased by 2.89% since.

Macy's is an omnichannel retailer. It sells merchandise, including men's, women's and children's apparel and accessories, cosmetics, home furnishings and other consumer goods. The company has a market cap of $8.61 billion. Its shares traded at $28.26 with a price-earnings (P/E) ratio of 5.61 on Friday.

Net income for the fourth quarter of 2017 was $1.33 billion compared to $475 million for the comparable period of 2016.

Director Gary Lambert Bentham bought 370 shares on April 6 at a price of $6.

Director Roger H. Giovanetto sold 143 shares on April 5 at a price of $5.86.

Executive Vice President, Controller and Enterprise Risk Felicia Williams sold 785 shares on Mar. 28 at a price of $28.99. The price of the stock has decreased by 2.52% since.

Aclaris Therapeutics CEO bought 10,000 shares

Aclaris Therapeutics Inc. (NASDAQ:ACRS) President and CEO Neal Walker bought 10,000 shares on April 5 at a price of $16.75. The price of the stock has increased by 5.19% since.

Aclaris Therapeutics is a clinical-stage specialty pharmaceutical company that focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company has a market cap of $544.48 million. Its shares traded at $17.62 with a price-earnings (P/E) ratio of on Friday.

Net loss for the fourth quarter of 2017 was $22.9 million compared to $11.5 million for the fourth quarter of 2016.

CFO Frank Ruffo bought 1,250 shares on April 6 at a price of $16.59. The price of the stock has increased by 6.21% since.

Director Stephen A. Tullman bought 26,700 shares on April 6 at a price of $16.54. The price of the stock has increased by 6.53% since.

Director Christopher P. Molineaux sold 2,300 shares on April 6 at a price of $16.52. The price of the stock has increased by 6.66% since.

For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Joy Hu


User Generated Screeners


Yamil BerardTepper's Leisure
jtepper2GrowthHighROC
gluon71gm-buylist-4
gluon71gm-buylist-3
DBrizancdn 18Jul2018 1249p
DBrizancdn 18Jul2018 1248p
HOLKLSUTop 20 Group 2018 All Sectors
DBrizancdn 18Jul2018 1219p
averacjrgood beta in up market
Nightdoc2S&P 500 quality
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK